Sacroplasty with or without screw fixation for sacral metastatic tumors
PSFS may provide additional benefit for patients with pathological fractures, while sacroplasty alone may be sufficient for those with impending pathologic fractures secondary to sacral metastatic disease. This study was limited by its retrospective design and sample size; however, the results may aid in treatment indications for sacral metastases and guide further research <i>Level of Evidence</i> Level III, Therapeutic Study.
Authors
- Matthew J. Scheidt (ORCID: https://orcid.org/0000-0001-9747-0436)
- Sean Tutton (ORCID: https://orcid.org/0000-0002-5876-9993)
- Adam N. Wooldridge (ORCID: https://orcid.org/0000-0003-0279-8266)
- John C. Neilson (ORCID: https://orcid.org/0000-0002-1295-5192)
- Donald A. Hackbarth
- Meena Bedi (ORCID: https://orcid.org/0000-0002-3269-5711)
- David M. King (ORCID: https://orcid.org/0000-0002-5899-789X)
- Edwin B. Cox
- Brandon M. Key
Institutions
- Medical College of Wisconsin (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fonc.2025.1494377
- Citations
- 1
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 2.01